"O IBCC Oncologia é uma rede de serviços especializada em oncologia e em pessoas com câncer. Atuamos na conscientização, diagnóstico e tratamento do câncer de forma humanizada. Atualmente contamos com 4 unidades, sendo a primeira inaugurada há 51 anos na Mooca e outras na Vila Mariana, Jaçanã (SP) e Formosa (GO)."

During the past decade, Instituto Brasileiro de Controle Do Cancer IBCC conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 11 clinical trials were completed, i.e. on average, 28.9% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 5 clinical trials were completed. i.e. 22.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto Brasileiro de Controle Do Cancer IBCC" #1 sponsor was "Instituto Brasileiro de Controle do Cancer" with 8 trials, followed by "Latin American Cooperative Oncology Group" with 5 trials sponsored, "Bayer" with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored and "Eli Lilly and Company" with 4 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Brasileiro de Controle Do Cancer IBCC" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Laboratorio Elea Phoenix S.A." with 2 trials as a collaborator, "Libbs Farmacêutica LTDA" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator and "ADIR, a Servier Group company" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Instituto Brasileiro de Controle Do Cancer IBCC" are "Breast Cancer" (10 trials), "Metastatic Breast Cancer" (5 trials), "Breast Neoplasms" (2 trials), "Enhanced Recovery After Surgery" (2 trials) and "Lung Cancer" (2 trials). Many other conditions were trialed in "Instituto Brasileiro de Controle Do Cancer IBCC" in a lesser frequency.

Most popular intervention types in "Instituto Brasileiro de Controle Do Cancer IBCC" are "Drug" (37 trials), "Other" (6 trials), "Behavioral" (2 trials), "Biological" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Pertuzumab" (4 trials), "Trastuzumab" (4 trials), "Abemaciclib" (3 trials) and "Capecitabine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Brasileiro de Controle Do Cancer IBCC" are 25 trials for "All" genders, 18 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Instituto Brasileiro de Controle Do Cancer IBCC". undefined are not yet recruiting, 11 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Instituto Brasileiro de Controle Do Cancer IBCC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Brasileiro de Controle Do Cancer IBCC, 2 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Instituto Brasileiro de Controle Do Cancer IBCC has several departments that took part in Clinical trials: "Núcleo de Pesquisa São Camilo; ONCOLOGIA CLINICA / QUIMIOTERAPIA" - 8 trials